11-119027762-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001164278.2(SLC37A4):c.492C>A(p.Ser164Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000368 in 1,612,762 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. S164S) has been classified as Likely benign.
Frequency
Consequence
NM_001164278.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC37A4 | NM_001164278.2 | c.492C>A | p.Ser164Arg | missense_variant | 5/12 | NP_001157750.1 | ||
SLC37A4 | NM_001164277.2 | c.492C>A | p.Ser164Arg | missense_variant | 5/11 | NP_001157749.1 | ||
SLC37A4 | NM_001164280.2 | c.492C>A | p.Ser164Arg | missense_variant | 3/9 | NP_001157752.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC37A4 | ENST00000330775.9 | c.492C>A | p.Ser164Arg | missense_variant | 4/10 | 5 | ENSP00000476242.2 |
Frequencies
GnomAD3 genomes AF: 0.000236 AC: 36AN: 152266Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000162 AC: 40AN: 246696Hom.: 0 AF XY: 0.000157 AC XY: 21AN XY: 133864
GnomAD4 exome AF: 0.000382 AC: 558AN: 1460496Hom.: 0 Cov.: 35 AF XY: 0.000332 AC XY: 241AN XY: 726438
GnomAD4 genome AF: 0.000236 AC: 36AN: 152266Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74396
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 07, 2022 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 27001614) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Apr 09, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 06, 2015 | - - |
Glucose-6-phosphate transport defect Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | This sequence change replaces serine, which is neutral and polar, with arginine, which is basic and polar, at codon 164 of the SLC37A4 protein (p.Ser164Arg). This variant is present in population databases (rs369399624, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with SLC37A4-related conditions. ClinVar contains an entry for this variant (Variation ID: 496949). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC37A4 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The p.S164R variant (also known as c.492C>A), located in coding exon 3 of the SLC37A4 gene, results from a C to A substitution at nucleotide position 492. The serine at codon 164 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at